Scientists explore way to deliver treatment for eye disease - KXLT - Fox 47 Rochester MN News, Weather, Sports #rochmn

Scientists explore better way to deliver treatment for eye disease

Updated: April 2, 2014 02:13 PM

WEDNESDAY, April 2, 2014 (HealthDay News) -- Scientists may have found a new method for treating age-related macular degeneration, a leading cause of blindness.

People with the condition suffer a loss of central vision, and those with advanced stages of the disease can't read, watch TV, drive or use computers.

There are two forms of age-related macular degeneration, dry and wet. Dry age-related macular degeneration accounts for the majority of cases, but wet age-related macular degeneration causes more than 90 percent of the associated cases of blindness. Blindness in people with the wet form of the disease is caused by abnormal growth of blood vessels behind the retina, scientists note.

In this study, researchers found that a protein called IL-18 protects eyesight by preventing the production of abnormal blood vessels behind the retina. They also found that IL-18 seems effective when given intravenously instead of through injections directly into the eye.

"We were initially concerned that IL-18 might cause damage to the sensitive cells of the retina, because it is typically linked to inflammation," study first author Sarah Doyle, an assistant professor of immunology at Trinity College Dublin in Ireland, said in a college news release.

"But surprisingly we found that low doses had no adverse effects on the retina and yet still suppressed abnormal blood vessel growth," Doyle said.

The study was published online April 2 in Science Translational Medicine. It was partially supported by pharmaceutical maker GlaxoSmithKline.

Currently, treatment options for wet age-related macular degeneration are limited to the advanced stages of the disease and involve regular injections directly into the eye, according to the news release.

More information

The U.S. National Eye Institute has more about age-related macular degeneration.

Copyright © 2014 HealthDay. All rights reserved.

*DISCLAIMER*: The information contained in or provided through this site section is intended for general consumer understanding and education only and is not intended to be and is not a substitute for professional advice. Use of this site section and any information contained on or provided through this site section is at your own risk and any information contained on or provided through this site section is provided on an "as is" basis without any representations or warranties.
Powered by WorldNow

Fox 

47

Main Station: 507-252-4747
6301 Bandel Road NW
Rochester, MN 55901

Newsroom: 507-281-4747
Tollfree: 1-877-FOX47TV
news@myfox47.com

Powered by WorldNow
All content © Copyright 2000 - 2014 WorldNow and KXLT. All Rights Reserved.
For more information on this site, please read our Privacy Policy and Terms of Service and Mobile Privacy Policy & Terms of Service.

Persons with disabilities who need assistance with issues relating to the content of this station's public inspection file should contact Administrative Assistant Jodi Neyens at (507) 280-5104. Questions or concerns relating to the accessibility of the FCC's online public file system should be directed to the FCC at 888-225-5322, at 888-835-5322 (TTY) or at fccinfo@fcc.gov.